These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 2422998)
21. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. Harker WG; Kushlan P; Rosenberg SA Ann Intern Med; 1984 Oct; 101(4):440-6. PubMed ID: 6206757 [TBL] [Abstract][Full Text] [Related]
22. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863 [TBL] [Abstract][Full Text] [Related]
23. ABVD chemotherapy in the treatment of Hodgkin's disease. Bonadonna G; Santoro A Cancer Treat Rev; 1982 Mar; 9(1):21-35. PubMed ID: 6175409 [No Abstract] [Full Text] [Related]
24. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. Oberlin O; Leverger G; Pacquement H; Raquin MA; Chompret A; Habrand JL; Terrier-Lacombe MJ; Bey P; Bertrand Y; Rubie H J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434 [TBL] [Abstract][Full Text] [Related]
25. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial. Glick JH; Young ML; Harrington D; Schilsky RL; Beck T; Neiman R; Fisher RI; Peterson BA; Oken MM J Clin Oncol; 1998 Jan; 16(1):19-26. PubMed ID: 9440718 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi. Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405 [TBL] [Abstract][Full Text] [Related]
27. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. Carde P; Hagenbeek A; Hayat M; Monconduit M; Thomas J; Burgers MJ; Noordijk EM; Tanguy A; Meerwaldt JH; Le Fur R J Clin Oncol; 1993 Nov; 11(11):2258-72. PubMed ID: 7693881 [TBL] [Abstract][Full Text] [Related]
28. Is there an effective salvage therapy for advanced Hodgkin's disease? Canellos GP Ann Oncol; 1991 Jan; 2 Suppl 1():1-7. PubMed ID: 1710484 [TBL] [Abstract][Full Text] [Related]
29. More than MOPP for advanced Hodgkin's disease? Mayer RJ N Engl J Med; 1982 Apr; 306(13):800-2. PubMed ID: 6174866 [No Abstract] [Full Text] [Related]
30. [Controversy regarding the treatment of Hodgkin's disease]. Balwierz W; Armata J Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966 [No Abstract] [Full Text] [Related]
31. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Santoro A; Bonfante V; Bonadonna G Ann Intern Med; 1982 Feb; 96(2):139-43. PubMed ID: 6174060 [TBL] [Abstract][Full Text] [Related]
32. Treatment for localized Hodgkin's disease. Crowther D Hematol Oncol; 1984; 2(1):63-6. PubMed ID: 6203822 [No Abstract] [Full Text] [Related]
33. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. Delwail V; Jais JP; Colonna P; Andrieu JM Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147 [TBL] [Abstract][Full Text] [Related]
34. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149 [TBL] [Abstract][Full Text] [Related]
35. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results. Bonadonna G; Santoro A; Bonfante V; Valagussa P Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323 [TBL] [Abstract][Full Text] [Related]
37. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118 [TBL] [Abstract][Full Text] [Related]
38. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis. Skoetz N; Trelle S; Rancea M; Haverkamp H; Diehl V; Engert A; Borchmann P Lancet Oncol; 2013 Sep; 14(10):943-52. PubMed ID: 23948348 [TBL] [Abstract][Full Text] [Related]
39. Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience. Bonadonna G; Santoro A; Gianni AM; Viviani S; Siena S; Bregni M; Zucali R; Lombardi F; Bonfante V; Gianni L Ann Oncol; 1991 Jan; 2 Suppl 1():9-16. PubMed ID: 1710489 [TBL] [Abstract][Full Text] [Related]
40. [Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease]. Płuzańska A; Berner J; Kowalczyński M; Dowgier-Witczak I; Chmielowska E; Woźniak L Pol Arch Med Wewn; 1986 May; 75(5):344-50. PubMed ID: 2431397 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]